T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant.
about
Distinct roles of CD4+ T cell subpopulations in retroviral immunity: lessons from the Friend virus mouse modelUse of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 regionAn epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans.Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like proteinImmunity to retroviral infection: the Friend virus modelVaccination with a live retrovirus: the nature of the protective immune responseRecombinant vaccinia virus vaccine against the human melanoma antigen p97 for use in immunotherapyProtection against establishment of retroviral persistence by vaccination with a live attenuated virus.Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1-infected individual.Characterization of a live-attenuated retroviral vaccine demonstrates protection via immune mechanisms.Critical role for CD4(+) T cells in controlling retrovirus replication and spread in persistently infected mice.Requirement for CD4(+) T cells in the Friend murine retrovirus neutralizing antibody response: evidence for functional T cells in genetic low-recovery miceLymphocyte deficiencies increase susceptibility to friend virus-induced erythroleukemia in Fv-2 genetically resistant miceKinetics of the development of protective immunity in mice vaccinated with a live attenuated retrovirus.Role of natural killer cells in resistance against friend retrovirus-induced leukemiaInterference established in mice by infection with Friend murine leukemia virusVaccinia virus vectors: new strategies for producing recombinant vaccines.Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1.Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector.Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitroHelper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide.Fv1 restriction and retrovirus vaccine immunity in Apobec3-deficient 129P2 mice.Current approaches to vaccine preparation.Novel role of CD8(+) T cells and major histocompatibility complex class I genes in the generation of protective CD4(+) Th1 responses during retrovirus infection in mice.Differing T-cell requirements for recombinant retrovirus vaccines.Induction of anti-gp160 cytotoxic T cells cross-reacting with various V3 loop P18 peptides in human immunodeficiency virus type 1 envelope-immunized individuals.Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus-induced tumors.No evidence for xenotropic murine leukemia-related virus infection in Sweden using internally controlled multiepitope suspension array serology.Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.Genetic control of T cell responsiveness to the Friend murine leukemia virus envelope antigen. Identification of class II loci of the H-2 as immune response genesFBL-reactive CD8+ cytotoxic and CD4+ helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigens.An evaluation of the potential to use tumor-associated antigens as targets for antitumor T cell therapy using transgenic mice expressing a retroviral tumor antigen in normal lymphoid tissues.Contrasting effects from a single major histocompatibility complex class II molecule (H-2E) in recovery from Friend virus leukemiaIncreased hematopoiesis in mice soon after infection by Friend murine leukemia virus.Multiplicity of virus-encoded helper T-cell epitopes expressed on FBL-3 tumor cells.The amino-terminal half of rotavirus SA114fM VP4 protein contains a hemagglutination domain and primes for neutralizing antibodies to the virus.Protective cellular retroviral immunity requires both CD4+ and CD8+ immune T cells.Role and specificity of T-cell subsets in spontaneous recovery from Friend virus-induced leukemia in mice.Protection against Friend retrovirus-induced leukemia by recombinant vaccinia viruses expressing the gag gene.Induction of complement-dependent and -independent neutralizing antibodies by recombinant-derived human cytomegalovirus gp55-116 (gB)
P2860
Q27003380-37F58D2D-4A21-4616-9AFC-7FA02EAC365EQ27480326-BA81D6B5-9EBA-40B5-ABAF-ED75EEB2D212Q27485984-4EFF3F4B-891D-497E-8624-0B289C22087AQ27486239-58424169-6FB5-4C27-83BB-1A394AC0E741Q28243606-C86CB856-8D27-4325-9A6C-638403C50ECEQ28335614-3F17F0F2-0DD1-4CCB-97E7-F12CBAFD27D0Q33552626-20B719F4-8932-46DE-80F7-C9AFF5596A6FQ33646493-D62A5DAB-2CAC-4C72-B57D-DA7F89294FD6Q33671780-FCA960CB-6785-4D6E-B4A5-CE293A739F38Q33783464-53CFFA31-DDAE-4E22-95B3-36E02299C751Q33783475-E9B1CEF5-0309-4192-8F01-E9AF93BD7585Q33785520-55B5EE7E-3F52-402A-9656-5D6C9196B985Q33816934-46EC88C8-10AF-48E3-A344-1FAFFC27FBD4Q33820285-F50777F9-412A-434B-81A9-C2BBC8C7A66FQ33838025-05CB06C6-BAC8-4D88-A768-9699A1C16174Q33937915-9472FD11-9382-41C5-AE62-07E77864BDE9Q34211635-F764D94D-555C-4728-8894-AEBD6C40DD56Q34323839-4CD7D8D7-31CB-4ADE-B8FF-D4FED64EB416Q34350358-4171277D-53B5-4847-893E-2A07AAD943ADQ34570241-5496C9B3-4080-4A39-8920-FF17C36188C1Q34632476-7E28BA4D-6915-4010-ACDB-46FB56D51D83Q34638103-0DD7787E-80FD-4644-AF49-34A5D606ECCEQ34688016-1DD08C73-3F0F-4E87-8A1F-D9116E51A2CDQ35000685-8149244D-B673-4F8D-975B-BDF2B01268EAQ35853685-A81443C7-1592-456A-9C45-E7086ADEF4E2Q35869862-40F77E66-2AE2-486F-BC02-43490449B40FQ35872183-8879604B-6358-4EA7-98E1-051581AB7D82Q36191612-DA1F2432-D01B-41CB-B322-03C7E3D3B713Q36232089-7EB648F0-E6CA-4FCB-AB86-974092244F2AQ36355568-F16B1F55-B2CB-44E0-A402-C26B63F7D601Q36355924-75F4C0C9-EAD4-4D5D-BEDC-10EAF94F0621Q36361846-48D79C43-4C6C-432C-87FF-42CC24F28CDBQ36624380-4289F540-A8B7-441E-AFAC-F52DF08A00F9Q36649211-8F868524-058F-43DE-B596-5560880D01FBQ36650857-40AF449C-2906-4001-BD99-884880242E8BQ36682311-36A559A3-C245-4597-AB70-2EE3F191B50AQ36687914-1BC3FE0B-6C39-4A74-B866-413C5D807260Q36697793-DCBAEA79-0747-494B-8FC0-C84F8802ACC3Q36699099-A398E00E-066B-4F6A-8F2E-C2739A4098C5Q36872453-F4A54C14-4303-4A70-91BF-DC197870D23A
P2860
T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
T-lymphocyte priming and prote ...... trovirus env gene recombinant.
@en
type
label
T-lymphocyte priming and prote ...... trovirus env gene recombinant.
@en
prefLabel
T-lymphocyte priming and prote ...... trovirus env gene recombinant.
@en
P2093
P356
P1433
P1476
T-lymphocyte priming and prote ...... trovirus env gene recombinant.
@en
P2093
P304
P356
10.1126/SCIENCE.3490689
P407
P577
1986-11-01T00:00:00Z